Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Supply, Demand and Key Producers, 2023-2029
The global Inactivated Vaccine for Swine Mycoplasma Pneumonia market size is expected to reach $ 568.1 million by 2029, rising at a market growth of 7.1% CAGR during the forecast period (2023-2029).
Inactivated vaccines for Swine Mycoplasma pneumonia are also available. They are made by using inactivated or killed strains of the bacteria to stimulate an immune response in pigs without causing disease.
This report studies the global Inactivated Vaccine for Swine Mycoplasma Pneumonia production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Vaccine for Swine Mycoplasma Pneumonia, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Vaccine for Swine Mycoplasma Pneumonia that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia total production and demand, 2018-2029, (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia total production value, 2018-2029, (USD Million)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia domestic production, consumption, key domestic manufacturers and share
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Pulike Biotech and Qilu Animal Health Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Vaccine for Swine Mycoplasma Pneumonia market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market, By Region:
1. How big is the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
2. What is the demand of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
3. What is the year over year growth of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
4. What is the production and production value of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
5. Who are the key producers in the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
6. What are the growth factors driving the market demand?
Inactivated vaccines for Swine Mycoplasma pneumonia are also available. They are made by using inactivated or killed strains of the bacteria to stimulate an immune response in pigs without causing disease.
This report studies the global Inactivated Vaccine for Swine Mycoplasma Pneumonia production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Vaccine for Swine Mycoplasma Pneumonia, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Vaccine for Swine Mycoplasma Pneumonia that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia total production and demand, 2018-2029, (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia total production value, 2018-2029, (USD Million)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia domestic production, consumption, key domestic manufacturers and share
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Jinhe Biotechnology, Merck, HIPRA, Ceva Sant? Animale, Harbin Pharmaceutical Group, Pulike Biotech and Qilu Animal Health Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Vaccine for Swine Mycoplasma Pneumonia market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single Vaccine
- Dual Vaccine
- Piglets
- Adult Pigs
- Zoetis
- Boehringer Ingelheim
- Jinhe Biotechnology
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Pulike Biotech
- Qilu Animal Health Products
- Wuhan Keqian Biology
1. How big is the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
2. What is the demand of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
3. What is the year over year growth of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
4. What is the production and production value of the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
5. Who are the key producers in the global Inactivated Vaccine for Swine Mycoplasma Pneumonia market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Introduction
1.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Supply & Forecast
1.2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018 & 2022 & 2029)
1.2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.2.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Pricing Trends (2018-2029)
1.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (Based on Production Site)
1.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018-2029)
1.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2018-2029)
1.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2018-2029)
1.3.4 North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.5 Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.6 China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.7 Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Demand (2018-2029)
2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region
2.2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2018-2023)
2.2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Forecast by Region (2024-2029)
2.3 United States Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.4 China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.5 Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.6 Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.7 South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.8 ASEAN Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.9 India Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
3 WORLD INACTIVATED VACCINE FOR SWINE MYCOPLASMA PNEUMONIA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Manufacturer (2018-2023)
3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Manufacturer (2018-2023)
3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Manufacturer (2018-2023)
3.4 Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Vaccine for Swine Mycoplasma Pneumonia in 2022
3.5.3 Global Concentration Ratios (CR8) for Inactivated Vaccine for Swine Mycoplasma Pneumonia in 2022
3.6 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Overall Company Footprint Analysis
3.6.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Region Footprint
3.6.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Type Footprint
3.6.3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison
4.1.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison
4.2.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison
4.3.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.4.3 United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
4.5 China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share
4.5.1 China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.5.3 China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
4.6 Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Single Vaccine
5.2.2 Dual Vaccine
5.3 Market Segment by Type
5.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2018-2029)
5.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2018-2029)
5.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adult Pigs
6.3 Market Segment by Application
6.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2018-2029)
6.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2018-2029)
6.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.1.4 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Details
7.2.2 Boehringer Ingelheim Major Business
7.2.3 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.2.4 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.3 Jinhe Biotechnology
7.3.1 Jinhe Biotechnology Details
7.3.2 Jinhe Biotechnology Major Business
7.3.3 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.3.4 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jinhe Biotechnology Recent Developments/Updates
7.3.6 Jinhe Biotechnology Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.4.4 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 HIPRA
7.5.1 HIPRA Details
7.5.2 HIPRA Major Business
7.5.3 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.5.4 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 HIPRA Recent Developments/Updates
7.5.6 HIPRA Competitive Strengths & Weaknesses
7.6 Ceva Sant? Animale
7.6.1 Ceva Sant? Animale Details
7.6.2 Ceva Sant? Animale Major Business
7.6.3 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.6.4 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Ceva Sant? Animale Recent Developments/Updates
7.6.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Details
7.7.2 Harbin Pharmaceutical Group Major Business
7.7.3 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.7.4 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.7.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.8 Pulike Biotech
7.8.1 Pulike Biotech Details
7.8.2 Pulike Biotech Major Business
7.8.3 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.8.4 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pulike Biotech Recent Developments/Updates
7.8.6 Pulike Biotech Competitive Strengths & Weaknesses
7.9 Qilu Animal Health Products
7.9.1 Qilu Animal Health Products Details
7.9.2 Qilu Animal Health Products Major Business
7.9.3 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.9.4 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Qilu Animal Health Products Recent Developments/Updates
7.9.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.10.4 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Chain
8.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Upstream Analysis
8.2.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Core Raw Materials
8.2.2 Main Manufacturers of Inactivated Vaccine for Swine Mycoplasma Pneumonia Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Mode
8.6 Inactivated Vaccine for Swine Mycoplasma Pneumonia Procurement Model
8.7 Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Sales Model and Sales Channels
8.7.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Model
8.7.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Introduction
1.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Supply & Forecast
1.2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018 & 2022 & 2029)
1.2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.2.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Pricing Trends (2018-2029)
1.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (Based on Production Site)
1.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018-2029)
1.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2018-2029)
1.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2018-2029)
1.3.4 North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.5 Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.6 China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.3.7 Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Demand (2018-2029)
2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region
2.2.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2018-2023)
2.2.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Forecast by Region (2024-2029)
2.3 United States Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.4 China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.5 Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.6 Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.7 South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.8 ASEAN Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
2.9 India Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029)
3 WORLD INACTIVATED VACCINE FOR SWINE MYCOPLASMA PNEUMONIA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Manufacturer (2018-2023)
3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Manufacturer (2018-2023)
3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Manufacturer (2018-2023)
3.4 Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Vaccine for Swine Mycoplasma Pneumonia in 2022
3.5.3 Global Concentration Ratios (CR8) for Inactivated Vaccine for Swine Mycoplasma Pneumonia in 2022
3.6 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Overall Company Footprint Analysis
3.6.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Region Footprint
3.6.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Type Footprint
3.6.3 Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison
4.1.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison
4.2.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison
4.3.1 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.4.3 United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
4.5 China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share
4.5.1 China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.5.3 China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
4.6 Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Single Vaccine
5.2.2 Dual Vaccine
5.3 Market Segment by Type
5.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2018-2029)
5.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2018-2029)
5.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adult Pigs
6.3 Market Segment by Application
6.3.1 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2018-2029)
6.3.2 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2018-2029)
6.3.3 World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.1.4 Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Details
7.2.2 Boehringer Ingelheim Major Business
7.2.3 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.2.4 Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.2.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.3 Jinhe Biotechnology
7.3.1 Jinhe Biotechnology Details
7.3.2 Jinhe Biotechnology Major Business
7.3.3 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.3.4 Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jinhe Biotechnology Recent Developments/Updates
7.3.6 Jinhe Biotechnology Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.4.4 Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 HIPRA
7.5.1 HIPRA Details
7.5.2 HIPRA Major Business
7.5.3 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.5.4 HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 HIPRA Recent Developments/Updates
7.5.6 HIPRA Competitive Strengths & Weaknesses
7.6 Ceva Sant? Animale
7.6.1 Ceva Sant? Animale Details
7.6.2 Ceva Sant? Animale Major Business
7.6.3 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.6.4 Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Ceva Sant? Animale Recent Developments/Updates
7.6.6 Ceva Sant? Animale Competitive Strengths & Weaknesses
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Details
7.7.2 Harbin Pharmaceutical Group Major Business
7.7.3 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.7.4 Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.7.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
7.8 Pulike Biotech
7.8.1 Pulike Biotech Details
7.8.2 Pulike Biotech Major Business
7.8.3 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.8.4 Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pulike Biotech Recent Developments/Updates
7.8.6 Pulike Biotech Competitive Strengths & Weaknesses
7.9 Qilu Animal Health Products
7.9.1 Qilu Animal Health Products Details
7.9.2 Qilu Animal Health Products Major Business
7.9.3 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.9.4 Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Qilu Animal Health Products Recent Developments/Updates
7.9.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
7.10.4 Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Chain
8.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Upstream Analysis
8.2.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Core Raw Materials
8.2.2 Main Manufacturers of Inactivated Vaccine for Swine Mycoplasma Pneumonia Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Mode
8.6 Inactivated Vaccine for Swine Mycoplasma Pneumonia Procurement Model
8.7 Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Sales Model and Sales Channels
8.7.1 Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Model
8.7.2 Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018-2023) & (USD Million)
Table 3. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2024-2029) & (USD Million)
Table 4. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2018-2023)
Table 5. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2024-2029)
Table 6. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2018-2023) & (K Units)
Table 7. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2024-2029) & (K Units)
Table 8. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2018-2023)
Table 9. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2024-2029)
Table 10. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Market Trends
Table 13. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2018-2023) & (K Units)
Table 15. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Vaccine for Swine Mycoplasma Pneumonia Producers in 2022
Table 18. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Inactivated Vaccine for Swine Mycoplasma Pneumonia Producers in 2022
Table 20. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Evaluation Quadrant
Table 22. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Site of Key Manufacturer
Table 24. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Type Footprint
Table 25. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Application Footprint
Table 26. Inactivated Vaccine for Swine Mycoplasma Pneumonia Competitive Factors
Table 27. Inactivated Vaccine for Swine Mycoplasma Pneumonia New Entrant and Capacity Expansion Plans
Table 28. Inactivated Vaccine for Swine Mycoplasma Pneumonia Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 37. China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 42. Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 47. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2018-2023) & (K Units)
Table 49. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2024-2029) & (K Units)
Table 50. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2018-2023) & (USD Million)
Table 51. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2024-2029) & (USD Million)
Table 52. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2018-2023) & (K Units)
Table 56. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2024-2029) & (K Units)
Table 57. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2018-2023) & (USD Million)
Table 58. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2024-2029) & (USD Million)
Table 59. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 64. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Major Business
Table 69. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 70. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim Recent Developments/Updates
Table 72. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 73. Jinhe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Jinhe Biotechnology Major Business
Table 75. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 76. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jinhe Biotechnology Recent Developments/Updates
Table 78. Jinhe Biotechnology Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 82. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. HIPRA Basic Information, Manufacturing Base and Competitors
Table 86. HIPRA Major Business
Table 87. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 88. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. HIPRA Recent Developments/Updates
Table 90. HIPRA Competitive Strengths & Weaknesses
Table 91. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 92. Ceva Sant? Animale Major Business
Table 93. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 94. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Ceva Sant? Animale Recent Developments/Updates
Table 96. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 97. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 98. Harbin Pharmaceutical Group Major Business
Table 99. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 100. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Harbin Pharmaceutical Group Recent Developments/Updates
Table 102. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 103. Pulike Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Pulike Biotech Major Business
Table 105. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 106. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pulike Biotech Recent Developments/Updates
Table 108. Pulike Biotech Competitive Strengths & Weaknesses
Table 109. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Animal Health Products Major Business
Table 111. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 112. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Qilu Animal Health Products Recent Developments/Updates
Table 114. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 115. Wuhan Keqian Biology Major Business
Table 116. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 117. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Inactivated Vaccine for Swine Mycoplasma Pneumonia Upstream (Raw Materials)
Table 119. Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Customers
Table 120. Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Distributors
Table 1. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2018-2023) & (USD Million)
Table 3. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Region (2024-2029) & (USD Million)
Table 4. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2018-2023)
Table 5. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2024-2029)
Table 6. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2018-2023) & (K Units)
Table 7. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Region (2024-2029) & (K Units)
Table 8. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2018-2023)
Table 9. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2024-2029)
Table 10. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Inactivated Vaccine for Swine Mycoplasma Pneumonia Major Market Trends
Table 13. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption by Region (2018-2023) & (K Units)
Table 15. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Vaccine for Swine Mycoplasma Pneumonia Producers in 2022
Table 18. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Inactivated Vaccine for Swine Mycoplasma Pneumonia Producers in 2022
Table 20. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Company Evaluation Quadrant
Table 22. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Site of Key Manufacturer
Table 24. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Type Footprint
Table 25. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Company Product Application Footprint
Table 26. Inactivated Vaccine for Swine Mycoplasma Pneumonia Competitive Factors
Table 27. Inactivated Vaccine for Swine Mycoplasma Pneumonia New Entrant and Capacity Expansion Plans
Table 28. Inactivated Vaccine for Swine Mycoplasma Pneumonia Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 37. China Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 42. Rest of World Based Inactivated Vaccine for Swine Mycoplasma Pneumonia Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share (2018-2023)
Table 47. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2018-2023) & (K Units)
Table 49. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Type (2024-2029) & (K Units)
Table 50. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2018-2023) & (USD Million)
Table 51. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type (2024-2029) & (USD Million)
Table 52. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2018-2023) & (K Units)
Table 56. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production by Application (2024-2029) & (K Units)
Table 57. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2018-2023) & (USD Million)
Table 58. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application (2024-2029) & (USD Million)
Table 59. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 64. Zoetis Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Major Business
Table 69. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 70. Boehringer Ingelheim Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer Ingelheim Recent Developments/Updates
Table 72. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 73. Jinhe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Jinhe Biotechnology Major Business
Table 75. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 76. Jinhe Biotechnology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jinhe Biotechnology Recent Developments/Updates
Table 78. Jinhe Biotechnology Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 82. Merck Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. HIPRA Basic Information, Manufacturing Base and Competitors
Table 86. HIPRA Major Business
Table 87. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 88. HIPRA Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. HIPRA Recent Developments/Updates
Table 90. HIPRA Competitive Strengths & Weaknesses
Table 91. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 92. Ceva Sant? Animale Major Business
Table 93. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 94. Ceva Sant? Animale Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Ceva Sant? Animale Recent Developments/Updates
Table 96. Ceva Sant? Animale Competitive Strengths & Weaknesses
Table 97. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 98. Harbin Pharmaceutical Group Major Business
Table 99. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 100. Harbin Pharmaceutical Group Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Harbin Pharmaceutical Group Recent Developments/Updates
Table 102. Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
Table 103. Pulike Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Pulike Biotech Major Business
Table 105. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 106. Pulike Biotech Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pulike Biotech Recent Developments/Updates
Table 108. Pulike Biotech Competitive Strengths & Weaknesses
Table 109. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Animal Health Products Major Business
Table 111. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 112. Qilu Animal Health Products Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Qilu Animal Health Products Recent Developments/Updates
Table 114. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 115. Wuhan Keqian Biology Major Business
Table 116. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Product and Services
Table 117. Wuhan Keqian Biology Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Inactivated Vaccine for Swine Mycoplasma Pneumonia Upstream (Raw Materials)
Table 119. Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Customers
Table 120. Inactivated Vaccine for Swine Mycoplasma Pneumonia Typical Distributors
LIST OF FIGURES
Figure 1. Inactivated Vaccine for Swine Mycoplasma Pneumonia Picture
Figure 2. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 5. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price (2018-2029) & (US$/Unit)
Figure 6. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2018-2029)
Figure 7. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2018-2029)
Figure 8. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 9. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 10. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 11. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 12. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 15. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Region (2018-2029)
Figure 16. United States Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 17. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 18. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 19. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 20. South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 22. India Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Vaccine for Swine Mycoplasma Pneumonia Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Vaccine for Swine Mycoplasma Pneumonia Markets in 2022
Figure 26. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 30. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 32. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type in 2022
Figure 34. Single Vaccine
Figure 35. Dual Vaccine
Figure 36. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Type (2018-2029)
Figure 37. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type (2018-2029)
Figure 38. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application in 2022
Figure 41. Piglets
Figure 42. Adult Pigs
Figure 43. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Application (2018-2029)
Figure 44. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application (2018-2029)
Figure 45. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Chain
Figure 47. Inactivated Vaccine for Swine Mycoplasma Pneumonia Procurement Model
Figure 48. Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Model
Figure 49. Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Inactivated Vaccine for Swine Mycoplasma Pneumonia Picture
Figure 2. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 5. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price (2018-2029) & (US$/Unit)
Figure 6. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Region (2018-2029)
Figure 7. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Region (2018-2029)
Figure 8. North America Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 9. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 10. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 11. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Production (2018-2029) & (K Units)
Figure 12. Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 15. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share by Region (2018-2029)
Figure 16. United States Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 17. China Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 18. Europe Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 19. Japan Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 20. South Korea Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 22. India Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Inactivated Vaccine for Swine Mycoplasma Pneumonia by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Vaccine for Swine Mycoplasma Pneumonia Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Vaccine for Swine Mycoplasma Pneumonia Markets in 2022
Figure 26. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inactivated Vaccine for Swine Mycoplasma Pneumonia Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 30. China Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share 2022
Figure 32. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type in 2022
Figure 34. Single Vaccine
Figure 35. Dual Vaccine
Figure 36. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Type (2018-2029)
Figure 37. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Type (2018-2029)
Figure 38. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application in 2022
Figure 41. Piglets
Figure 42. Adult Pigs
Figure 43. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Market Share by Application (2018-2029)
Figure 44. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Production Value Market Share by Application (2018-2029)
Figure 45. World Inactivated Vaccine for Swine Mycoplasma Pneumonia Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Inactivated Vaccine for Swine Mycoplasma Pneumonia Industry Chain
Figure 47. Inactivated Vaccine for Swine Mycoplasma Pneumonia Procurement Model
Figure 48. Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Model
Figure 49. Inactivated Vaccine for Swine Mycoplasma Pneumonia Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
